Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs—First real world data from Austria

BACKGROUND: Directly acting antivirals (DAA) against hepatitis C virus (HCV) infection have facilitated sustained virologic response (SVR) rates >90% in clinical studies. Yet, real life data regarding DAA treatment in people who inject drugs (PWIDs) are scarce. We evaluated the effectiveness of g...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidbauer, Caroline, Schubert, Raphael, Schütz, Angelika, Schwanke, Cornelia, Luhn, Julian, Gutic, Enisa, Pirker, Roxana, Lang, Tobias, Reiberger, Thomas, Haltmayer, Hans, Gschwantler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064180/
https://www.ncbi.nlm.nih.gov/pubmed/32155165
http://dx.doi.org/10.1371/journal.pone.0229239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064180/
https://www.ncbi.nlm.nih.gov/pubmed/32155165
http://dx.doi.org/10.1371/journal.pone.0229239

Ejemplares similares